Literature DB >> 7767419

Cost-effectiveness of alternative screening strategies for developmental dysplasia of the hip.

K Rosendahl1, T Markestad, R T Lie, E Sudmann, J T Geitung.   

Abstract

OBJECTIVE: To compare the cost-effectiveness of adding either a general or a selective ultrasound screening program to the routine clinical examination for developmental dysplasia of the hip (DDH) with use of the data from a large, randomized study of 11,925 newborns.
METHODS: Our previous study comparing the clinical outcomes of three strategies for screening infants for DDH suggested (but results were not statistically significant) that general ultrasound screening resulted in fewer children requiring hospitalization and surgery for DDH than did a strategy based on ultrasound screening of the 11.8% of infants considered to be at increased risk of DDH or one with no ultrasound screening. General ultrasound screening led to early splinting of 3.4% of the newborns compared with 2.0% for the selectively screened group and 1.8% for the group not receiving ultrasound screening. Using these data, we decided on sequences and intervals of diagnostic and therapeutic actions considered to be sufficient for each regimen. We applied estimates of the costs of screening, treatment of DDH discovered early and late, and follow-up examinations to arrive at total program costs for each strategy.
RESULTS: Total program costs were similar for each of the three screening strategies (costs varied by < 5%). However, treatment of late cases accounted for only 22% of total costs in the group undergoing general screening vs 65% in the two latter groups. The cost estimates were sensitive to several variables. Application of the data to a hypothetical ultrasound program in which all girls and only boys at increased risk for DDH underwent an ultrasound examination showed substantially reduced total program costs.
CONCLUSIONS: Application of costs from other centers to our data regarding frequency of clinical outcomes may yield different comparative program costs. If the findings of our clinical study can be generalized to other centers, a strategy of screening all girls and boys with risk factors for DDH may be the most cost-effective approach.

Entities:  

Mesh:

Year:  1995        PMID: 7767419

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  13 in total

Review 1.  Preventive health care, 2001 update: screening and management of developmental dysplasia of the hip in newborns.

Authors:  H Patel
Journal:  CMAJ       Date:  2001-06-12       Impact factor: 8.262

2.  Ultrasound in the diagnosis of clinical orthopedics: The orthopedic stethoscope.

Authors:  Alexander Blankstein
Journal:  World J Orthop       Date:  2011-02-18

3.  Diagnosing developmental dysplasia of the hip using the Graf ultrasound method: risk and protective factor analysis in 11,820 universally screened newborns.

Authors:  Mohammad Schams; Rob Labruyère; Anne Zuse; Mikolaj Walensi
Journal:  Eur J Pediatr       Date:  2017-07-17       Impact factor: 3.183

4.  Selective ultrasound screening for developmental hip dysplasia: effect on management and late detected cases. A prospective survey during 1991-2006.

Authors:  Lene Bjerke Laborie; Trond Jacob Markestad; Henrik Davidsen; Kari Røine Brurås; Stein Magnus Aukland; John Asle Bjørlykke; Hallvard Reigstad; Kari Indrekvam; Trude Gundersen Lehmann; Ingvild Øvstebø Engesæter; Lars Birger Engesæter; Karen Rosendahl
Journal:  Pediatr Radiol       Date:  2013-12-13

5.  Early detection of developmental dysplasia of the hip in The Netherlands: the validity of a standardized assessment protocol in infants.

Authors:  M M Boere-Boonekamp; T H Kerkhoff; P B Schuil; G A Zielhuis
Journal:  Am J Public Health       Date:  1998-02       Impact factor: 9.308

6.  Implementation of a nationwide universal ultrasound screening programme for developmental dysplasia of the neonatal hip in Mongolia.

Authors:  Munkhtulga Ulziibat; Bayalag Munkhuu; Raoul Schmid; Thomas Baumann; Stefan Essig
Journal:  J Child Orthop       Date:  2020-08-01       Impact factor: 1.548

7.  Performance, treatment pathways, and effects of alternative policy options for screening for developmental dysplasia of the hip in the United Kingdom.

Authors:  C Dezateux; J Brown; R Arthur; J Karnon; A Parnaby
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

8.  Efficiency of alternative policy options for screening for developmental dysplasia of the hip in the United Kingdom.

Authors:  J Brown; C Dezateux; J Karnon; A Parnaby; R Arthur
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

9.  Monitoring of a hip surveillance programme protects infants from radiation and surgical intervention.

Authors:  David J Milligan; Aidan P Cosgrove
Journal:  Bone Joint J       Date:  2020-04       Impact factor: 5.082

10.  [Hip ultrasound screening in Germany. Results and comparison with other screening procedures].

Authors:  N Ihme; L Altenhofen; R von Kries; F U Niethard
Journal:  Orthopade       Date:  2008-06       Impact factor: 1.004

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.